Noroviruses: State of the Art

被引:92
作者
Atmar, Robert L. [1 ]
机构
[1] Baylor Coll Med, Dept Med, Houston, TX 77030 USA
基金
美国国家卫生研究院;
关键词
Norovirus; Gastroenteritis; Review; Human; Calicivirus; NORWALK VIRUS-INFECTION; CELLULAR IMMUNE-RESPONSES; BLOOD GROUP ANTIGENS; ACUTE GASTROENTERITIS; SRSV GASTROENTERITIS; UNITED-STATES; SNOW-MOUNTAIN; OUTBREAK; EPIDEMIOLOGY; RESISTANCE;
D O I
10.1007/s12560-010-9038-1
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Noroviruses are a common cause of both endemic and epidemic gastroenteritis. These highly infectious viruses usually cause self-limited disease, but chronic infections occur in highly immunocompromised patients and unusual manifestations are also being described in some populations. Histoblood-group antigen expression is now recognized as an important susceptibility factor for many norovirus strains, but a correlate of acquired immunity to infection or illness has not yet been identified. Currently, treatment and prevention strategies rely on nonspecific measures. However, virus-like particles containing capsid antigens are undergoing evaluation as a vaccine candidate for illness prevention. This article reviews the biologic properties, epidemiology, clinical features, host susceptibility, diagnosis, and treatment and prevention of norovirus infection.
引用
收藏
页码:117 / 126
页数:10
相关论文
共 90 条
[51]   THE ROLE OF THE PRESYMPTOMATIC FOOD HANDLER IN A COMMON SOURCE OUTBREAK OF FOOD-BORNE SRSV GASTROENTERITIS IN A GROUP OF HOSPITALS [J].
LO, SV ;
CONNOLLY, AM ;
PALMER, SR ;
WRIGHT, D ;
THOMAS, PD ;
JOYNSON, D .
EPIDEMIOLOGY AND INFECTION, 1994, 113 (03) :513-521
[52]   Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains [J].
LoBue, Anna D. ;
Lindesmith, Lisa ;
Yount, Boyd ;
Harrington, Patrick R. ;
Thompson, Joseph M. ;
Johnston, Robert E. ;
Moe, Christine L. ;
Baric, Ralph S. .
VACCINE, 2006, 24 (24) :5220-5234
[53]   Epidemiology and cost of nosocomial gastroenteritis, Avon, England, 2002-2003 [J].
Lopman, BA ;
Reacher, MH ;
Vipond, IB ;
Hill, D ;
Perry, C ;
Halladay, T ;
Brown, DW ;
Edmunds, WJ ;
Sarangi, J .
EMERGING INFECTIOUS DISEASES, 2004, 10 (10) :1827-1834
[54]   Clinical manifestation of norovirus gastroenteritis in health care settings [J].
Lopman, BA ;
Reacher, MH ;
Vipond, IB ;
Sarangi, J ;
Brown, DWG .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (03) :318-324
[55]   Host, Weather and Virological Factors Drive Norovirus Epidemiology: Time-Series Analysis of Laboratory Surveillance Data in England and Wales [J].
Lopman, Ben ;
Armstrong, Ben ;
Atchison, Christina ;
Gray, Jim J. .
PLOS ONE, 2009, 4 (08)
[56]   Immunity to calicivirus infection [J].
Matsui, SM ;
Greenberg, HB .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 :S331-S335
[57]   Human noroviruses in swine and cattle [J].
Mattison, Kirsten ;
Shukla, Anu ;
Cook, Angela ;
Pollari, Frank ;
Friendship, Robert ;
Kelton, David ;
Bidawid, Sabah ;
Farber, Jeffrey M. .
EMERGING INFECTIOUS DISEASES, 2007, 13 (08) :1184-1188
[58]   Risk groups for clinical complications of norovirus infections: an outbreak investigation [J].
Mattner, F ;
Sohr, D ;
Heim, A ;
Gastmeier, P ;
Vennema, H ;
Koopmans, M .
CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 (01) :69-74
[59]   Evolution of human calicivirus RNA in vivo: Accumulation of mutations in the protruding P2 domain of the capsid leads to structural changes and possibly a new phenotype [J].
Nilsson, M ;
Hedlund, KO ;
Thorhagen, M ;
Larson, G ;
Johansen, K ;
Ekspong, A ;
Svensson, L .
JOURNAL OF VIROLOGY, 2003, 77 (24) :13117-13124
[60]  
Noel JS, 1997, J MED VIROL, V53, P372, DOI 10.1002/(SICI)1096-9071(199712)53:4<372::AID-JMV10>3.0.CO